Albemarle Q3 Adjusted EBITDA Jumps 186% as Lithium Prices Rebound; Specialties Outlook Raised
ALB is trading near its 52-week low of $88.01 (7.9% above the low) on elevated volume (2.5× avg).
Summary
Albemarle posted Q3 2026 net sales of $1.6 billion, up 19%, and net income of $297 million, or $2.15 per diluted share, versus a loss a year ago. Adjusted EBITDA of $646 million rose 186%, driven by Energy Storage realized pricing of $20.02/kg LCE versus $10.28 a year earlier, even as segment sales volume fell 19%. The company raised its Specialties adjusted EBITDA outlook to $350-$375 million from $275-$325 million and cut full-year capex to $300-$350 million from roughly $500 million, while delivering more than $150 million of year-to-date run-rate cost savings. The catch is the forward curve: management said Q4 net sales and adjusted EBITDA will fall sequentially on lower market pricing and consumption of higher-cost spodumene inventory. Full-year 2026 adjusted EBITDA guidance spans $0.9-$1.0 billion at ~$10/kg lithium to $2.4-$2.6 billion at ~$20/kg, so the stock remains a leveraged bet on lithium prices. This follows the October 30 8-K closing a $1.5 billion revolver and the September 3 announcement that BHP's Ragnar Udd becomes CEO on February 1, 2027. Earnings call is November 5 at 8:00 AM ET.
At the time of this announcement, ALB was trading at $94.97 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $11.2B. The 52-week trading range was $88.01 to $221.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.